Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus

QR Code

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus

The emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus closely related to SARS-CoV and officially known as <i>Betacoronavirus pandemicum</i> precipitated a substantial surge in vaccine development that culminated during the global COVID-19 pandemic. A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sofia M. Gulova, Uliana S. Veselkina, Irina V. Astrakhantseva
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Vaccines
Subjects:	SARS-CoV-2 vaccine viral evolution pan-coronavirus vaccine viral variants immune evasion
Online Access:	https://www.mdpi.com/2076-393X/13/7/761
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections
by: Francisco Muñoz-López, et al.
Published: (2025-06-01)

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants
by: Hawa Vahed, et al.
Published: (2025-12-01)

Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea
by: Sangyi Lee, et al.
Published: (2023-12-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Structural insights on the differentiation and reversion of conformational changes in SARS-CoV-2 spike protein models across variants occurring from December, 2019 to November, 2021
by: Marni E. Cueno, et al.
Published: (2025-09-01)

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications
by: Alaa A. A. Aljabali, et al.
Published: (2025-07-01)

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
by: Hailong Guo, et al.
Published: (2023-12-01)

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
by: Jesse M. van den Berg, et al.
Published: (2025-05-01)

Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US
by: Nicholas F. G. Chen, et al.
Published: (2025-07-01)

A Novel SARS-CoV-2-Derived Infectious Vector System
by: Ghada Elfayres, et al.
Published: (2025-06-01)

One-Year Monitoring of the Evolution of SARS-CoV-2 Omicron Subvariants Through Wastewater Analysis (Central Italy, August 2023–July 2024)
by: Alessandra Nappo, et al.
Published: (2025-05-01)

SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients
by: Eva Ulla Lorentzen, et al.
Published: (2025-05-01)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

Case report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2)
by: S. V. Zhuravel’, et al.
Published: (2021-04-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Rabies virus-based oral and inactivated vaccines protect minks against SARS-CoV-2 infection and transmission
by: Hong Huo, et al.
Published: (2025-03-01)

Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants
by: Joyhare Barbosa Souza, et al.
Published: (2025-04-01)

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024-12-01)

Structural basis for varying drug resistance of SARS-CoV-2 Mpro E166 variants
by: Morgan A. Esler, et al.
Published: (2025-07-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes
by: Rory Williams, et al.
Published: (2025-05-01)

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
by: Rui Qiao, et al.
Published: (2025-06-01)

Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
by: F. D. Partey, et al.
Published: (2025-07-01)

The Characteristics of the Delta Variant of SARS-CoV-2 Virus – the Dominant Agent of the Third and Forth Waves of Epidemic COVID-19 in Russia
by: T. E. Sizikova, et al.
Published: (2023-06-01)

SARS-CoV-2 spike protein mutation variants: Recent advances in theragnostic and vaccines development
by: Jutishna Bora, et al.
Published: (2025-08-01)

Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
by: Mariangela Scavone, et al.
Published: (2025-07-01)

Analysis of phosphomotifs coupled to phosphoproteome and interactome unveils potential human kinase substrate proteins in SARS-CoV-2
by: Vineetha Shaji, et al.
Published: (2025-07-01)

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines
by: Chengyu Hu, et al.
Published: (2025-06-01)

RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests
by: Richard Creager, et al.
Published: (2021-01-01)

Frequency of SARS-CoV-2 RNA Detection in Foreign Medical Students Vaccined against New Coronavirus Infection
by: O. A. Ryabtseva, et al.
Published: (2023-03-01)

Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice
by: Raj S. Patel, et al.
Published: (2025-07-01)

Some aspects of specific prevention of a new coronavirus infection caused by the SARS CoV-2 virus in the Samara region
by: A. I. Kiryukhin, et al.
Published: (2023-07-01)

New Evidence on the Evolution of the COVID-19 Pandemic: Literature Review
by: Leyla S. Namazova-Baranova, et al.
Published: (2021-10-01)

SARS-CoV-2 Delta variant induces severe damage in the nasal cavity from the first day post-infection in the Syrian hamster model
by: Maxime Fusade-Boyer, et al.
Published: (2025-12-01)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
by: Doris Urlaub, et al.
Published: (2021-12-01)

Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
by: A. V. Ivanov, et al.
Published: (2024-11-01)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)

Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
by: Lucia Inchauste, et al.
Published: (2025-07-01)

A study of the efficacy and safety of plaque psoriasis treatment by TNF‐α and IL‐17A inhibitor biologics in patients who received the inactivated SARS‐CoV‐2 vaccine
by: Shuhong Ye, et al.
Published: (2023-07-01)